GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹1,075 Cr | ₹1,219 Cr | ₹908 Cr | ₹972 Cr | ₹700 Cr |
What is the latest Short Term Loans and Advances ratio of GLENMARK PHARMACEUTICALS ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2025 | ₹1,075 Cr |
| Mar2024 | ₹1,219 Cr |
| Mar2023 | ₹908 Cr |
| Mar2022 | ₹972 Cr |
| Mar2021 | ₹700 Cr |
How is Short Term Loans and Advances of GLENMARK PHARMACEUTICALS Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,075 Cr | -11.83 | |
| Mar2024 | ₹1,219 Cr | 34.26 | |
| Mar2023 | ₹908 Cr | -6.63 | |
| Mar2022 | ₹972 Cr | 38.82 | |
| Mar2021 | ₹700 Cr | - | |
Compare Short Term Loans and Advances of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹56,916.9 Cr | 2.3% | -0.6% | 37.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹382,694.0 Cr | -2.3% | -7.3% | -12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,721.0 Cr | 0.8% | -5.8% | 4.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,016.0 Cr | 0.8% | 3.7% | 20.8% | Stock Analytics | |
| CIPLA | ₹106,946.0 Cr | 0.7% | -11.2% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,691.0 Cr | -1.4% | -3.8% | -1.3% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 2.3% |
-0.6% |
37.3% |
| SENSEX | -0.1% |
-2.9% |
7.5% |
You may also like the below Video Courses